Potential Clinical Applications for Human Pluripotent Stem Cell-Derived Blood Components
The ability of human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) to divide indefinitely without losing pluripotency and to theoretically differentiate into any cell type in the body makes them highly attractive cell sources for large scale regenerative medicine purposes....
Saved in:
| Main Authors: | Erin A. Kimbrel, Shi-Jiang Lu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2011-01-01
|
| Series: | Stem Cells International |
| Online Access: | http://dx.doi.org/10.4061/2011/273076 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical Application of Human Induced Pluripotent Stem Cell-Derived Organoids as an Alternative to Organ Transplantation
by: Gabriella Shih Ping Hsia, et al.
Published: (2021-01-01) -
Mitochondrial Maturation in Human Pluripotent Stem Cell Derived Cardiomyocytes
by: Dao-Fu Dai, et al.
Published: (2017-01-01) -
Generation and Applications of Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells
by: Chengzhu Zhao, et al.
Published: (2018-01-01) -
Comparison of human-induced pluripotent stem cell-derived macrophages with peripheral blood-derived macrophages using single-cell genomics
by: ZHANG Yutong, et al.
Published: (2024-12-01) -
NEXN deficiency leads to dilated cardiomyopathy in human pluripotent stem cell-derived cardiomyocytes
by: Mengqi Jiang, et al.
Published: (2025-07-01)